Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 800 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/16/16
End: 02/14/20
Due: 02/14/21
Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer
Phase: N/A
Priority: Normal
Start: 02/29/00
End: 05/31/01
Due: 05/31/02
Phase: N/A
Priority: Normal
Start: 04/27/10
End: 02/04/20
Due: 02/04/21
Phase: N/A
Priority: Normal
Start: 03/30/20
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 01/14/20
End: 09/07/20
Due: 09/07/21
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 07/01/18
Due: 07/01/19
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 02/15/19
End: 07/20/21
Due: 07/20/22
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 09/15/20
End: 09/15/24
Due: 09/15/25
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 07/04/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 03/02/18
Due: 03/02/19
Phase: N/A
Priority: Normal
Start: 04/04/23
End: 04/25/23
Due: 04/25/24
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 08/18/20
End: 08/16/24
Due: 08/16/25
Phase: N/A
Priority: Normal
Start: 09/26/19
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 06/04/19
End: 10/30/25
Due: 10/30/26
Phase: N/A
Priority: Normal
Start: 07/24/20
End: 05/18/23
Due: 05/18/24
Phase: N/A
Priority: Normal
Start: 12/18/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/24/22
End: 05/11/23
Due: 05/11/24